Company profile

Livongo

Chronic Disease Management & Digital Therapeutics

Company profile

About Livongo

Livongo by Teladoc Health is a comprehensive digital chronic condition management platform that serves over 730,000 patients with conditions including diabetes, hypertension, and weight challenges. The company provides a one-of-a-kind approach combining connected health-monitoring devices, certified health coaches, and support from physicians and mental health specialists. Members receive smart devices such as blood glucose meters with unlimited strips, blood pressure monitors, and connected scales that automatically upload health data. The platform offers personalized health plans tailored to individual lifestyles, goals, and health data, with support available in multiple languages including Spanish. Livongo's program is based on clinical standards of care from leading organizations including the American Diabetes Association, American Heart Association, and Centers for Disease Control and Prevention. The service includes unlimited access to dedicated health coaches who monitor diet, exercise, medication, motivation, nutrition, and mental health. With 24/7 monitoring capabilities, the team proactively reaches out when dangerous health levels are detected. The platform has demonstrated significant clinical outcomes, including a 48% reduced incidence of diabetes over three years, 15mmHg average systolic blood pressure reduction, and 46% of patients losing 5% or more of their starting weight. Livongo is available at no cost to eligible members through their employer, health plan, or healthcare provider, and includes a mobile app for tracking progress and accessing personalized insights.

Company description Livongo official website

Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Livongo?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Hypertension
  • Obesity
  • Pre-diabetes
  • Type 1 diabetes
  • Type 2 diabetes
  • Weight management

Who it serves

  • Employers
  • Health Plans
  • Healthcare Providers

Deployment & integration

Cloud Saas deployment with recorded integration context.

Geographic context

MarketsUnited States
Company sourceOfficial website

Company milestones

Platform expansion

Serving 730,000+ patients, GLP-1 medication prescribing capability added to condition management programs

Partnerships

Recorded partners

  • American Diabetes Association
  • American Heart Association
  • Centers for Disease Control and Prevention

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Livongo Diabetes Management

Personalized tools and support to track blood sugar levels and develop healthier lifestyle habits

Platform · Cloud SaaSCompany source

Livongo Diabetes Prevention Program

Get ahead of diabetes with medically certified content, activity tracking and ongoing coaching

Platform · Cloud SaaSCompany source

Livongo Hypertension Management

Discover lifestyle changes that can reduce blood pressure with daily tracking and support

Platform · Cloud SaaSCompany source

Livongo Weight Management

Find tips and techniques that work for you to improve nutrition, exercise and weight loss

Platform · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

48% reduced incidence of diabetes

Over a three-year period for diabetes prevention program participants

15mmHg average systolic blood pressure reduction

For hypertension management program participants

46% of patients lost 5% or more of their starting weight

For weight management program participants

Reduced medication usage

Due to healthier lifestyle changes across programs

Livongo Patient Population - Diabetes Prevention

Diabetes prevention through lifestyle modification and coaching

48% reduced incidence of diabetes over a three-year period

Livongo Patient Population - Hypertension

Blood pressure reduction through monitoring and lifestyle changes

15mmHg average systolic blood pressure reduction

Livongo Patient Population - Weight Management

Weight loss through personalized coaching and tracking

46% of patients lost 5% or more of their starting weight

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Livongo

Recent articles published on Livongo's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Chronic Disease Management & Digital Therapeutics

Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon